Cas:615568-24-6 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde manufacturer & supplier

Chemical Name:2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde

CAS.NO:615568-24-6

Synonyms:2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde

Molecular Formula:C₈H₇NO₃

Molecular Weight:165.146

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:293.0±28.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.595

PSA:48.42000

Exact Mass:165.042587

LogP:1.45

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde Use and application,2,3-dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde technical grade,usp/ep/jp grade.

Related News: Moreover, the improved stereoselectivity further enhances product purity by ensuring that only one stereoisomer reacts where a mixture of stereoisomers is present. 3a,7-Ethano-3aH-indene-4,7a(1H)-diol,tetrahydro-6-methyl-1-methylene-,(3aS,4R,6S,7S,7aS)-(9CI) manufacturers The plant will complement Recipharm’s existing sites in France, Germany and Italy and will be focused on securing approvals from regulators in Europe and the U.S. 2-Aziridinecarbonitrile, 1-(2-thienylcarbonyl)- suppliers Wavelength Pharmaceuticals will pay an undisclosed sum to buy up a majority stake in Hyderabad’s Vanamali Organics, an Indian firm specializing in making drug intermediates and starting materials that will add to Wavelengths’ API contract manufacturing work, the company said in a release. 5H-Cyclopenta-p-dithiin,hexahydro-,trans-(8CI) vendor & factory Moreover, the improved stereoselectivity further enhances product purity by ensuring that only one stereoisomer reacts where a mixture of stereoisomers is present. ,Wavelength Pharmaceuticals will pay an undisclosed sum to buy up a majority stake in Hyderabad’s Vanamali Organics, an Indian firm specializing in making drug intermediates and starting materials that will add to Wavelengths’ API contract manufacturing work, the company said in a release.